We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.76B
1-Year Est. Return 62.41%
This Fund
S&P 500
This Quarter Est. Return
+7.76%
1 Year Est. Return
+62.41%
3 Year Est. Return
+179.84%
5 Year Est. Return
+371.69%
10 Year Est. Return
+1,534.25%
AUM
$4.75B
AUM Growth
+$529M
Cap. Flow
+$146M
Cap. Flow %
3.08%
Top 10 Hldgs %
47.97%
Holding
745
New
128
Increased
150
Reduced
259
Closed
162
Avg Time Held Equity + Options
3.8 quarters
Top 10 Avg Time Held Equity + Options
1.1 quarters
Top 20 Avg Time Held Equity + Options
1.1 quarters
Avg Time Held Equity only
3.9 quarters
Top 10 Avg Time Held Equity only
1.1 quarters
Top 20 Avg Time Held Equity only
1.1 quarters

Top Buys

Rank Stock Value
1
SGEN
Seagen Inc. Common Stock
SGEN
+$253M
2
PDCE
PDC Energy, Inc.
PDCE
+$210M
3
ISEE
IVERIC bio, Inc. Common Stock
ISEE
+$206M
4
SYNH
Syneos Health, Inc. Class A Common Stock
SYNH
+$135M
5
LSI
Life Storage, Inc.
LSI
+$87.5M

Top Sells

Rank Stock Value
1
FHN icon
First Horizon
FHN
+$179M
2
AQUA
Evoqua Water Technologies Corp. Common Stock
AQUA
+$146M
3
PRVB
Provention Bio, Inc. Common Stock
PRVB
+$70.5M
4
TSEM icon
Tower Semiconductor
TSEM
+$50.8M
5
XM
Qualtrics International Inc. Class A Common Stock
XM
+$45.3M

Sector Composition

Rank Sector Weight
1 Healthcare 32.35%
2 Technology 15.68%
3 Financials 11.99%
4 Miscellaneous 10.5%
5 Real Estate 8.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
EDIT icon
401
Editas Medicine
EDIT
$422M
$678K 0.01%
82,369
+18,319
+29% +$160K
2023 Q1
1 quarter
CRL icon
402
Charles River Laboratories
CRL
$14.4B
$675K 0.01%
3,211
+158
+5% +$31.4K
2022 Q4
2 quarters
PRAX icon
403
Praxis Precision Medicines
PRAX
$7.02B
$671K 0.01%
38,903
+5,086
+15% +$77.9K
2022 Q1
5 quarters
CNTB icon
404
Connect Biopharma Holdings
CNTB
$57M
$670K 0.01%
603,900
+29,752
+5% +$33.4K
2022 Q2
4 quarters
MRK icon
405
Merck
MRK
$359B
$668K 0.01%
5,790
-12,074
-68% -$1.37M
2022 Q3
3 quarters
AGNC icon
406
AGNC Investment
AGNC
$10.3B
$662K 0.01%
65,381
-81,571
-56% -$793K
2023 Q1
1 quarter
H icon
407
PUT
Hyatt Hotels
H
$15.2B
$661K 0.01%
237,000
+21,500
+10% +$2.43M
2022 Q1
5 quarters
W icon
408
Wayfair
W
$14.5B
$650K 0.01%
+10,000
New +$421K
2023 Q2
0 quarters
GEHC icon
409
GE HealthCare
GEHC
$30.6B
$637K 0.01%
7,835
-565
-7% -$45.1K
2022 Q4
2 quarters
AKTS icon
410
DELISTED
Akoustis Technologies Inc
AKTS
$636K 0.01%
200,000
+100,000
+100% +$307K
2022 Q4
2 quarters
MIRM icon
411
Mirum Pharmaceuticals
MIRM
$5.59B
$621K 0.01%
+24,000
New +$638K
2023 Q2
0 quarters
GTLS icon
412
DELISTED
Chart Industries
GTLS
$616K 0.01%
+3,856
New +$493K
2023 Q2
0 quarters
WIX icon
413
WIX.com
WIX
$3.1B
$587K 0.01%
+7,500
New +$617K
2023 Q2
0 quarters
KLRS icon
414
Kalaris Therapeutics
KLRS
$53.8M
$578K 0.01%
+7,391
New +$703K
2023 Q2
0 quarters
TRIP icon
415
TripAdvisor
TRIP
$1.02B
$577K 0.01%
35,000
+10,000
+40% +$169K
2023 Q1
1 quarter
LGIH icon
416
LGI Homes
LGIH
$1.02B
$577K 0.01%
+4,275
New +$513K
2023 Q2
0 quarters
NVNO icon
417
enVVeno Medical
NVNO
$5.66M
$575K 0.01%
5,338
+263
+5% +$34.2K
2022 Q1
5 quarters
KBR icon
418
KBR
KBR
$4.44B
$572K 0.01%
+8,792
New +$524K
2023 Q2
0 quarters
DOC icon
419
Healthpeak Properties
DOC
$13.1B
$547K 0.01%
+27,200
New +$565K
2023 Q2
0 quarters
ELAN icon
420
Elanco Animal Health
ELAN
$11.3B
$545K 0.01%
54,176
+12,176
+29% +$113K
2022 Q4
2 quarters
AURA icon
421
Aura Biosciences
AURA
$678M
$543K 0.01%
+44,000
New +$470K
2023 Q2
0 quarters
SLN icon
422
Silence Therapeutics
SLN
$600M
$541K 0.01%
98,326
+2,943
+3% +$17.7K
2022 Q2
4 quarters
PTON icon
423
PUT
Peloton Interactive
PTON
$2.26B
$532K 0.01%
300,000
-185,000
-38% -$1.57M
2023 Q1
1 quarter
LCA
424
DELISTED
Landcadia Holdings IV, Inc. Class A Common Stock
LCA
$515K 0.01%
50,644
-1,141
-2% -$11.5K
2021 Q2
8 quarters
RETA
425
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$510K 0.01%
5,000
-250
-5% -$23.7K
2023 Q1
1 quarter
15 16
17
18 19

Similar funds

FNBT
FineMark National Bank & Trust Fort Myers, Florida $3.2B AUM 18.28% 1-Year Est. Return
ACI
Alpha Cubed Investments Irvine, California $2.92B AUM 31.27% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
A
AlphaQuest New York $1.79B AUM 10.61% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
CB
Cadence Bank Tupelo, Mississippi $1.71B AUM 16.17% 1-Year Est. Return
JCM
Janney Capital Management Pittsburgh, Pennsylvania $1.59B AUM 23.25% 1-Year Est. Return
MPM
Meritage Portfolio Management Overland Park, Kansas $1.51B AUM 26.61% 1-Year Est. Return

UBS O'Connor's Q2 2023 Portfolio in Review

As of Q2 2023, UBS O'Connor held 745 positions worth $4.75B, up 13% from $4.22B the previous quarter. Its ten largest holdings account for 48% of the portfolio.

UBS O'Connor deployed $146M of net new capital in Q2 2023, opening 128 new positions and adding to 150 existing holdings. Its largest new stake was PDC Energy, Inc.: 3,101,445 shares worth $221M.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, up from 21% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Tower Semiconductor, an estimated $50.8M trimmed.

  • UBS O'Connor's largest Q2 2023 buy was PDC Energy, Inc.: 3,101,445 shares worth $221M.
  • UBS O'Connor added most to Seagen Inc. Common Stock in Q2 2023, an estimated $253M increase.
  • UBS O'Connor's biggest Q2 2023 reduction was Tower Semiconductor, cutting an estimated $50.8M.
  • UBS O'Connor fully exited First Horizon in Q2 2023, selling an estimated $179M.
  • UBS O'Connor's ten largest holdings make up 48% of its $4.75B portfolio in Q2 2023.
  • UBS O'Connor opened 128 new positions and closed 162 in Q2 2023.
  • UBS O'Connor's portfolio value rose 13% quarter-over-quarter to $4.75B.

Based on UBS O'Connor's 13F filing for Q2 2023, filed 14 Aug 2023.